MRO Magazine

Technavio Announces Top Seven Vendors in the Cardiac Rhythm Management Devices Market in China until 2020


July 6, 2016
By Business Wire News

LONDON

Technavio has announced the top seven leading vendors for the cardiac rhythm management devices market in Chinain their latest research report. To identify the top vendors, Technavio’s market research analysts have considered the top contributors to the overall revenue of this market. To calculate the market size, Technavio researchers have considered the revenue generated from the sales of:

  • Pacemakers
  • Implantable cardioverter defibrillators (ICDs)
  • CRT devices: Cardiac resynchronization therapy-defibrillator (CRT-D) and cardiac resynchronization therapy-pacemaker (CRT-P)

Request sample report: http://bit.ly/290l2dJ

“Cardiac disorders such as atrioventricular blocks, ventricular fibrillation, cardiac arrest, bradycardia, sick sinus syndrome, and tachycardia are becoming prevalent in China with each year. In 2014, the Chinese Society of Cardiology estimated that cardiovascular diseases accounted for 40% of the overall mortality rate in the country,” said Barath Palada, one of Technavio’s lead analysts for cardiovascular devices.

“A rise in the population of this age group will increase the prevalence of cardiac diseases. To cater to the rising prevalence of cardiac diseases, vendors are developing advanced cardiac rhythm management devices such as CRT-Ps, CRT-Ds, and ICDs,” added Barath.

Top seven leading vendors in the cardiac rhythm management devicesmarket in China:

BIOTRONIK (Beijing) Medical Devices

BIOTRONIK (Beijing) Medical Devices is a subsidiary of BIOTRONIK that engages in the manufacturing and marketing of a wide range of cardiac medical devices in China. The company is headquartered in Beijing, China. In August 2015, the company enrolled its first patient BIOFLOW-VI clinical study in China. The study demonstrates safety and efficacy of Orsiro hybrid drug eluting stent that support CFDA. BIOFLOW-VI is a randomized controlled clinical trial that enrolled around 440 patients at 15 study sites in China.

BSC Medical Device Technology (Shanghai)

BSC Medical Device Technology (Shanghai) was established in 1997 and is headquartered in Shanghai, China. The company develops, manufactures, and markets high-quality medical devices used for treating a wide range of medical conditions. It provides an extensive range of innovative products through its subsidiaries and divisions in China. It has subsidiaries in Beijing, Shanghai, and Guangzhou in China. The company engages in the R&D, manufacturing, and marketing of a wide range of cardiac medical devices. The company offers its cardiac medical devices such as ICDs, CRTs, and pacemakers through its cardiac rhythm management sub-segment and offers heart valve systems through its interventional cardiology sub-segment.

Cardiac Science

Cardiac Science was founded in 1913 and is headquartered in Waukesha, Wisconsin, US. The company manufactures and markets a wide range of medical devices including automated external defibrillators. It operates as a subsidiary of Aurora Capital Group. The company offers a wide range of cardiac rhythm management devices. Some of the key products are Powerheart G5 Trainer AED, Powerheart G3 Plus AED, Powerheart G3 Pro AED, Powerheart G5 AED, and Powerheart G3 Trainer AED. The company also provides rescue-ready services accessories.

Koninklijke Philips

Koninklijke Philips was incorporated in 1891 and is headquartered in Amsterdam, the Netherlands. It is a global leader in healthcare, lighting, consumer lifestyle, innovation, and services. The company has a strong brand value and enjoys a good market presence worldwide. As of May 2014, the company has an overall ranking of 296 in the Forbes 2000 list and is ranked 300th in sales, 71st in the world’s most valuable brands, 431st in profit, and 331st in market value. The company offers its cardiac rhythm management products through its subsidiaries Philips Healthcare (Suzhou) and Philips Patient Monitoring Systems China.

LivaNova

LivaNova was established in 1987 and is headquartered in London, UK. It is a medical technology company that engages in the R&D, manufacturing, and marketing of a wide range of cardiac surgery, cardiac rhythm management, and neuromodulation products worldwide. In October 2015, LivaNova’s subsidiary Cyberonics completed a merger with Sorin Group for USD 2.7 billion. The company after the merger of Sorin Group acquired tissue heart valves portfolio of Sorin.

Medtronic

Medtronic is founded in 1949 and is headquartered in Dublin, Ireland. It engages in the R&D, manufacturing, and marketing of a wide range of medical devices in more than 155 countries worldwide. In FY2015, it reported a revenue of USD 20.26 billion. As of June 2015, the company had more than 55,000 employees in 460 locations worldwide. The company engages in the R&D, manufacturing, and marketing of a wide range of cardiac medical devices such as pacemakers, ICDs, CRT-D, and CRT-P through its cardiac rhythm and heart failure disease management sub-segment and transcatheter heart valves through its coronary and structural heart disease management sub- segment of cardiac and vascular group segment.

St. Jude Medical

St. Jude Medical was incorporated in 1976 and is headquartered in Minnesota, US. The company engages in the R&D, manufacturing, and marketing of medical devices in the US and also internationally. In FY2015, the company generated USD 5.54 billion revenues. The company manufactures a wide range of cardiac rhythm management products in China through its subsidiary St. Jude Medical (Shanghai) and its subsidiary is headquartered in Shanghai, China.

Browse related reports:

Do you need a report on a market in a specific geographical cluster or country but can’t find what you’re looking for? Don’t worry, Technavio also takes client requests. Please contact enquiry@technavio.com with your requirements and our analysts will be happy to create a customized report just for you.

About Technavio

Technavio is a leading global technology research and advisory company. The company develops over 2000 pieces of research every year, covering more than 500 technologies across 80 countries. Technavio has about 300 analysts globally who specialize in customized consulting and business research assignments across the latest leading edge technologies.

Technavio analysts employ primary as well as secondary research techniques to ascertain the size and vendor landscape in a range of markets. Analysts obtain information using a combination of bottom-up and top-down approaches, besides using in-house market modeling tools and proprietary databases. They corroborate this data with the data obtained from various market participants and stakeholders across the value chain, including vendors, service providers, distributors, re-sellers, and end-users.

If you are interested in more information, please contact our media team at media@technavio.com.

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 630 333 9501
UK: +44 208 123 1770
www.technavio.com
media@technavio.com